glp 1 drugs adverse effects A Retrospective Comparative Analysis of Cutaneous Reactions in GLP-1 Agonist Therapies - JDDonline GLP-1 receptor agonists are increasingly

Third generation: multi-receptor agonists Tirzepatide targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously, producing greater metabolic effects than GLP-1 alone: Mounjaro , once-weekly injection for type 2 diabetes (FDA-approved 2022)

In a recent study by Ayeni et al

Semaglutide set the threshold at -15% in 2021, tirzepatide raised it to -21% in 2022, and retatrutide pushed it to -29% by the end of 2025

However, as we age or face daily environmental stressors, our natural levels can begin to decline

Paired with Niacinamide, which is Vitamin B3, this cream becomes a powerhouse